TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen. February 2, 2007
TCL Archive NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies July 30, 1999